Correspondence 0001104659-24-066623 from Zura Bio Ltd (ZURA)
Zura Bio Ltd
Date: May 30, 2024 · CIK: 0001855644 · Accession: 0001104659-24-066623
AI Filing Summary & Sentiment
File numbers found in text: 333-279719
Show Raw Text
CORRESP
1
filename1.htm
Zura Bio Limited
1489 W. Warm Springs Rd. #110
Henderson, NV 89014
May 30, 2024
Via Edgar
United States Securities and
Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Alan Campbell
RE:
Zura Bio Limited
Registration Statement
on Form S-1 (File No. 333-279719)
Acceleration Request
Requested Date: June
3, 2024
Requested Time: 4:00
P.M. Eastern Time
Dear Mr. Campbell,
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Zura Bio Limited (the “Registrant”) hereby requests that the U.S. Securities
and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration
Statement on Form S-1 (as amended, the “Registration Statement”) and declare the Registration Statement effective
on June 3, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally
request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Divakar Gupta, Sarah Sellers and Brandon
Fenn of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement
has been declared effective, please orally confirm that event with Brandon Fenn, counsel to the Registrant, at (212) 479-6626.
Very truly yours,
Zura Bio Limited
/s/ Verender Badial
Verender Badial
Chief Financial Officer
cc:
Divakar Gupta, Cooley LLP
Sarah Sellers, Cooley LLP
Brandon Fenn, Cooley LLP